Dr. Lau’s research seeks to develop epidemiological and statistical methods that can then be applied primarily to HIV cohort studies. He is interested in developing new methods and adapting approaches from other fields as novel solutions to specific epidemiologic questions. Examples include competing risk methodologies and extension to comparing multiple event types, random forests, bootstrap model averaging and multi-model inference.
Lab Website: Bryan Lau Lab
Learn more about clinical trials at Johns Hopkins Medicine.
Lau B, Thorne JE, Moore RD, et al. “Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada.” AIDS Research and Human Retroviruses. 2016 Jan;32(1):50-58.
Howe CJ, Cole SR, Lau B, Napravnik S, Eron JJ. “Selection bias due to loss to follow up in cohort studies.” Epidemiology. 2016 Jan;27(1):91-97.
Turnbull AE, O’Connor CL, Lau B, Halpern SD, Needham DM. “Allowing physicians to choose the value of compensation for participation in a web-based survey: randomized controlled trial.” Journal of Medical Internet Research. 2015 Jul;17(7):e189.
Koethe JR, Jenkins CA, Lau B, Shepherd BE, Silverberg MJ, Brown TT, Blashill AJ, Anema A, Willig A, Stinnette S, Napravnik S, Gill J, Crane HM, Sterling TR. “Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010.” HIV Medicine. 2015 Oct;16(9):572-77.
Chander G, Hutton HE, Lau B, Xu X, McCaul ME. “Brief intervention decreases drinking frequency in HIV-infected, heavy drinking women: results of a randomized controlled trial.” Journal of Acquired Immune Deficiency Syndromes. 2015 Oct;70(2):137-45.
Lau B, Althoff KN, D’Souza G, Kirk GD, Modur SP, et al. “Cumulative incidence of cancer among persons with HIV in North America: a cohort study.” Annals of Internal Medicine. 2015 Oct;163(7):507-18.
Abraham AG, Althoff KN, Estrella MM, Moore RD, Golub ET, Jacobson LP, Lucas GM, Kirk GD, Gebo KA, Thorne JE, Gange SJ, Lau B, et al. “End-stage renal disease among HIV-infected adults in North America.” Clinical Infectious Diseases. 2015;60(6):941-9.
Cole SR, Lau B, Eron JJ, Brookhart MA, Kitahata MM, Martin JN, Mathews WC, Mugavero MJ. “Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy.” Am J Epidemiol. 2015;181(4):238-245.